跳至主要内容

Medicilon’s Protein Purification Services

 Medicilon’s protein scientists have been working on protein expression and purification for many years.  We can start your project even you have nothing in hand but the name of your protein.  In Medicilon’s laboratories, protein purification is performed in scales from micrograms and milligrams.  All Protein Purification Services start with the analysis of physico-chemical and biological properties of a target protein resulting in the development of tailored procedures for its extraction, purification and characterization. More Information》》

protein purificationKey Benefits from Medicilon for Protein Purification

quickly obtain proteins for research purposes such as:

  • evaluating their biological activities
  • inducing antibodies
  • use as research reagents
  • outsource your tough purification problems

Types of Protein

  • Native proteins from natural sources
  • Antibodies of different isotypes including IgMs
  • Enzymes
  • Growth factors
  • DNA binding proteins
  • Blood proteins
  • Membrane proteins
  • Fusion and tagged recombinant proteins

Scales

  • Analytical to preparative scale
  • Microgram to multi-gram quantities

Systems

  • Ion-exchange Chromatography
  • Size Exclusion Chromatography
  • Hydrophobic Interaction Chromatography
  • Affinity Chromatography (Ni, Co, FLAG, maltose, glutathione, protein A/G)
  • Displacement Chromatography

Protein purification methods range from affinity chromatography using various tags including His, Strep, Rho1D4, and others, classical chromatography such as ion exchange and size exclusion for polishing to protein-specific affinity chromatography which takes protein purification to the next level and allows for the enrichment of active protein conformations.

Protein Expression Systems at Shanghai Medicilon Inc.

We will work with you to set milestones for your project. We will provide you detailed results of each milestones to ensure you are confident for continuing the project.

Contact us

Email : marketing@medicilon.com

Tel : +44 1223 981 792（Europe）

        +82 (0)70-8269-5849（South Korea）

        08044216898（Japan）

        +86 021 58591500（China )

Website: https://www.medicilon.com

Related Articles:

Protein Purification Service Company

Protein Purification Service

Inclusion body protein purification and renaturation

Protein Purification Service Company

Protein extraction and purification techniques

Protein separation and purification technology service company

Protein expression and purification experiments

Protein Production Systems and Purification

Recombinant Protein Expression and Purification Services

标签：

评论

发表评论

此博客中的热门博文

What is preclinical testing?

In the process of  preclinical testing  of a compound or biological agent into a drug, the compound involved must go through the testing phase. First, we need to identify potential targets that can treat the disease. Then, a variety of compounds or preparations are screened out. Any compound that has shown potential as a drug for the treatment of this disease needs to be tested for toxicity before clinical testing to reduce the possibility of injury. preclinical testing What is the basis of preclinical testing? According to US Food and Drug Administration (FDA) regulations, a series of tests are required before a new drug is approved for use. In the first stage, basic research determines a hypothetical target for the treatment of a certain disease, and then screens small molecules or biological compounds to discover any substance with the potential to treat the disease. Then, a  preclinical research  phase followed, before which, as described above, the potential toxicity of the compou
发表评论
阅读全文

Inventory of the three major in vitro pharmacokinetic research methods

  The metabolic properties of a compound are an essential factor in whether or not it can be used as a drug in the clinical setting, so pharmacokinetic studies of newly synthesized compounds are required in drug development. In vitro incubation with liver microsomes, recombinant CYP450 enzyme lines, and in vitro incubation with hepatocytes are some of the more common in vitro drug metabolism methods. 1. In vitro incubation method with liver microsomes The metabolic stability and metabolic phenotypes of candidate compounds in different species of liver microsomes are good predictors of the metabolic properties of compounds in vivo. They are practical tools for evaluating candidate compounds in the pre-development phase of drug development. Liver microsomes include rat liver microsomes, human liver microsomes, canine liver microsomes, monkey liver microsomes, and mouse liver microsomes. In in vitro incubation of the liver, microsomes are the "gold standard" for in vitro d
发表评论
阅读全文

Novel Parkinson’s Therapies Possible with New Mouse Model

Parkinson's disease (PD) is a neurodegenerative disorder that is marked by the accumulation of the protein, α-synuclein (αS), into clumps known as Lewy bodies, which diminish neural health. Now, researchers from Brigham and Women's Hospital (BWH) report the development of a mouse model to induce PD-like αS aggregation, leading to resting tremor and abnormal movement control. The mouse responds to L-DOPA, similarly to patients with PD. The team's study (“Abrogating Native α-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson’s Disease”) on the use of this transgenic mouse model appears in  Neuron . “α-Synuclein (αS) regulates vesicle exocytosis but forms insoluble deposits in PD. Developing disease-modifying therapies requires animal models that reproduce cardinal features of PD. We recently described a previously unrecognized physiological form of αS, α-helical tetramers, and showed that familial PD-causing missense mutati
发表评论
阅读全文